Monthly healthcare membership now provides consumers with savings of up to 90% at more than 1,200 Publix locations

GoodRx, the leading destination for prescription savings in the U.S., today announced that Publix has joined the GoodRx Gold network. Members now have access to prescription savings of up to 90%¹ at more than 1,200 Publix pharmacy locations across the Southeast.

GoodRx Gold is a monthly healthcare membership that gives consumers access to discounted prices on their medications, with more than 1,000 popular prescriptions priced at less than $10. In addition, Gold offers telehealth visits with licensed healthcare professionals for as low as $19, free home delivery, and a dedicated support team.

“We are excited to bring Publix, one of the largest regional supermarket chains in the country, into the Gold network,” said Jim Sheninger, Pharmacy Strategy Officer at GoodRx. “As we continue our mission of making prescriptions more affordable and accessible, the expansion of GoodRx Gold into Publix will offer even more opportunities for consumers to see meaningful savings on their much-needed medications.”

To join GoodRx Gold, consumers simply need to sign up for the program online or via the GoodRx app, and then present their GoodRx Gold card at the pharmacy counter to access savings. Individual plans are available for $9.99 per month and family plans are available for up to six people for $19.99 per month. In 2023, GoodRx Gold individual plan members saved an average of $3,961 for the year on retail prescription prices, while family plan members saved an average of $5,177 for the year.²

GoodRx Gold is currently available in 49 states and Puerto Rico. Consumers can use GoodRx’s pharmacy directory to find a Gold pharmacy nearby.

To learn more, visit: www.goodrx.com/gold

About GoodRx

GoodRx is the leading destination for prescription savings in the U.S. We offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. We also equip healthcare professionals with efficient ways to find and prescribe affordable medications. Since 2011, GoodRx has helped consumers save more than $70 billion.

GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission (the “SEC”) and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding consumer savings; the benefits and value of our offerings to consumers, the U.S. healthcare system and GoodRx; GoodRx’s direct contracting approach; and GoodRx’s plans, expectations and objectives. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits, changes in medication pricing and pricing structures, our reliance on a limited number of industry participants, the competitive nature of our industry, risks related to government regulation of the internet, e-commerce, consumer data and privacy, information technology and cyber-security and the important factors discussed in the section entitled “Risk Factors” in GoodRx’s Annual Report on Form 10-K for the year ended December 31, 2023, and our other filings with the Securities and Exchange Commission. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240402103579/en/